Investors & Media

Cell Theranostics, Ltd. (“Cell Theranostics”) is progressing with the completion of the documents required by the Cayman Islands Registrar of Companies. When the Registrar confirms the authorization of the additional requested shares, the issuance of such shares will be made to Cell>Point who will then issue the shares to all of the Cell>Point members. Cell Theranostics, is currently in discussions with institutional funds about crossover funding which is critical  to the IPO process. Cell Theranostics is working diligently to complete the institutional funding. Beginning next quarter, Cell Theranostics, will begin issuing quarterly reports as Cell>Point has done in the past. As you may know, Cell Theranostics, will have a full management structure and this process has begun as well. We want to thank all of you for your patience in bearing with this process.

Investor Information:

Access Private Login Area: